ES2545614T3 - Proteínas truncadas con nudo de cistina - Google Patents

Proteínas truncadas con nudo de cistina Download PDF

Info

Publication number
ES2545614T3
ES2545614T3 ES10705010.6T ES10705010T ES2545614T3 ES 2545614 T3 ES2545614 T3 ES 2545614T3 ES 10705010 T ES10705010 T ES 10705010T ES 2545614 T3 ES2545614 T3 ES 2545614T3
Authority
ES
Spain
Prior art keywords
amino acid
acid sequence
cystine knot
growth factor
length
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10705010.6T
Other languages
English (en)
Spanish (es)
Inventor
Peter Timmerman
Wouter Cornelis Puijk
Tilman Mathias Hackeng
Arjan Willem Griffioen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pepscan Systems BV
Universiteit Maastricht
Maastricht University Medical Centre
Original Assignee
Pepscan Systems BV
Universiteit Maastricht
Maastricht University Medical Centre
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pepscan Systems BV, Universiteit Maastricht, Maastricht University Medical Centre filed Critical Pepscan Systems BV
Application granted granted Critical
Publication of ES2545614T3 publication Critical patent/ES2545614T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES10705010.6T 2009-02-06 2010-02-05 Proteínas truncadas con nudo de cistina Active ES2545614T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09152305 2009-02-06
EP09152305 2009-02-06
PCT/NL2010/050053 WO2010090523A1 (en) 2009-02-06 2010-02-05 Truncated cystine-knot proteins

Publications (1)

Publication Number Publication Date
ES2545614T3 true ES2545614T3 (es) 2015-09-14

Family

ID=40834444

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10705010.6T Active ES2545614T3 (es) 2009-02-06 2010-02-05 Proteínas truncadas con nudo de cistina

Country Status (8)

Country Link
US (1) US8772236B2 (cg-RX-API-DMAC7.html)
EP (1) EP2393832B1 (cg-RX-API-DMAC7.html)
JP (2) JP2012517425A (cg-RX-API-DMAC7.html)
AU (1) AU2010211438B2 (cg-RX-API-DMAC7.html)
CA (1) CA2751445C (cg-RX-API-DMAC7.html)
ES (1) ES2545614T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ594481A (cg-RX-API-DMAC7.html)
WO (1) WO2010090523A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010090523A1 (en) 2009-02-06 2010-08-12 Pepscan Systems B.V. Truncated cystine-knot proteins
US11078248B2 (en) 2010-03-19 2021-08-03 Lifenet Health BMP peptides and methods of use
JP5905446B2 (ja) 2010-03-24 2016-04-20 ライフネット ヘルス Bmp−4ペプチドおよび使用方法
UA112981C2 (uk) * 2011-04-11 2016-11-25 Елі Ліллі Енд Компані Варіант людського gdnf
US20150064163A1 (en) * 2011-09-02 2015-03-05 Lifenet Health BMP Peptides & Methods of Use
CN105085652B (zh) * 2014-05-16 2021-06-22 中国人民解放军军事医学科学院生物工程研究所 血小板衍生生长因子b突变体、其制备方法及用途
CU24637B1 (es) * 2019-12-24 2022-12-12 Ct Ingenieria Genetica Biotecnologia Polipéptidos que comprenden mutantes del vegf-a humano con re-arreglos de puentes disulfuro y composiciones que los contienen
US12703712B2 (en) 2021-03-30 2026-08-11 Transitions Optical, Ltd. Indenonaphthopyrans having trialkylsilyl and ethylenically unsaturated groups

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05501500A (ja) * 1989-10-18 1993-03-25 クリエイティブ・バイオマリキュールズ・インコーポレーテッド TGF―βの生合成構築物
JP3762222B2 (ja) 1998-10-07 2006-04-05 ストライカー・コーポレーション 改変型TGF−βスーパーファミリータンパク質
US7105481B2 (en) * 1998-11-10 2006-09-12 Ludwig Institute For Cancer Research Method for stimulating connective tissue growth or wound healing
JP2002534061A (ja) 1998-11-10 2002-10-15 ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ 血小板由来増殖因子d、それをコードするdna、及びその利用法
US20040009535A1 (en) * 1998-11-27 2004-01-15 Celltech R&D, Inc. Compositions and methods for increasing bone mineralization
PT1140175E (pt) * 1998-12-21 2006-06-30 Ludwig Inst Cancer Res Anticorpos para o vegf-d truncado e suas utilizacoes
EP1125905A1 (en) 2000-02-16 2001-08-22 Pepscan Systems B.V. Segment synthesis
EP1197755A1 (en) 2000-10-11 2002-04-17 Pepscan Systems B.V. Identification of protein binding sites
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
CA2567805A1 (en) * 2004-05-27 2005-12-15 Acceleron Pharma Inc. Tgf derepressors and uses related thereto
US20100322945A1 (en) 2006-07-26 2010-12-23 Peter Timmerman Immunogenic compounds and protein mimics
GB0710457D0 (en) * 2007-05-31 2007-07-11 Ark Therapeutics Ltd Vegf Mutants
WO2010090523A1 (en) 2009-02-06 2010-08-12 Pepscan Systems B.V. Truncated cystine-knot proteins

Also Published As

Publication number Publication date
EP2393832B1 (en) 2015-07-08
CA2751445C (en) 2018-06-19
AU2010211438A1 (en) 2011-09-01
WO2010090523A1 (en) 2010-08-12
US20120231000A1 (en) 2012-09-13
JP2012517425A (ja) 2012-08-02
US8772236B2 (en) 2014-07-08
JP6215879B2 (ja) 2017-10-18
JP2015193662A (ja) 2015-11-05
AU2010211438B2 (en) 2016-04-14
NZ594481A (en) 2012-09-28
CA2751445A1 (en) 2010-08-12
EP2393832A1 (en) 2011-12-14

Similar Documents

Publication Publication Date Title
ES2533874T3 (es) Armazón proteico
ES2558330T3 (es) Péptido WT1 restringido por HLA-A*3303 y composición farmacéutica que comprende el mismo
ES2535084T3 (es) Proteínas N-glicosiladas recombinantes procedentes de células procariotas
ES2616658T3 (es) Péptidos que mimetizan el factor de crecimiento y sus usos
ES2573108T3 (es) Proteínas de armazón a base de fibronectina que tienen estabilidad mejorada
ES2523837T3 (es) Agentes de unión específica al factor de crecimiento de hepatocitos
PL1966240T6 (pl) Peptydy laktoferyny użyteczne jako peptydy penetrujące komórkę
ES2513392T3 (es) Materiales biológicos y usos de los mismos
ES2691539T3 (es) Luciferasas de Oplophorus sintéticas con mayor emisión de luz
AR109355A2 (es) Moléculas de unión al receptor ox40 humano
MX383664B (es) Uso de un péptido para modular la homeostasis de los ácidos biliares o tratamiento de una enfermedad relacionada con los ácidos biliares.
AR076349A1 (es) Peptido auxiliar del antigeno del cancer
AR049177A1 (es) Polipeptidos y conjugados de interferon-alfa
AR076977A1 (es) Proteinas precursoras repetitivas autoensambladas
NO20092774L (no) HLA-A*1101-begrenset WT1-peptid og farmasoytisk preparat som omfatter dette
AR080229A1 (es) Proteinas de dominio de armazon de fibronectina que se unen a il -23 (interleucina 23)
AR072159A1 (es) Analogos de glucagon, basados en (peptido insulinotropico dependiente de la glucosa) gip para el tratamiento de trastornos metabolicos y obesidad
PT2121731E (pt) Vacinas peptídicas para cancros que expressam antigénios associados a tumores
CR10591A (es) Metodo para la produccion de conjugados del factor de crecimiento similar a la insulina-1 y polietilenglicol
ES2525758T3 (es) Composición que comprende un péptido y un inhibidor de la neuraminidasa vírica
CL2019003410A1 (es) Péptido asociado a tumor (tumap) aislado; ácido nucleico; vector de expresión; célula huésped recombinante que comprende el péptido; método para producir el péptido; uso para preparar un medicamento útil para tratar el cáncer; kit farmacéutico. (divisional solicitud 201702407).
AR064707A1 (es) Moleculas de transorte utilizando polipeptidos hiv -tat de secuencia inversa
RU2015103816A (ru) ПРОНИКАЮЩИЕ В КЛЕТКУ ПЕПТИДЫ, МИШЕНЬЮ КОТОРЫХ ЯВЛЯЕТСЯ eIF4E
CL2017000200A1 (es) Célula huésped mejorada para producir proteinas
AR067980A1 (es) Peptidos de cdh3 y agentes que los comprenden